133 related articles for article (PubMed ID: 6697813)
21. Potentiation of chemotherapeutic effect of vincristine in vincristine resistant tumor bearing mice by calmodulin inhibitor clomipramine.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
J Pharmacobiodyn; 1983 Feb; 6(2):145-7. PubMed ID: 6864439
[TBL] [Abstract][Full Text] [Related]
22. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
Góra-Tybor J; Robak T
Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
[TBL] [Abstract][Full Text] [Related]
23. Treatment of murine testicular leukemia.
Hoots WK; Nelson JA
Cancer Res; 1984 Jun; 44(6):2464-6. PubMed ID: 6722788
[TBL] [Abstract][Full Text] [Related]
24. In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia.
Kamath NS; Chitnis MP
Oncology; 1990; 47(2):166-9. PubMed ID: 2314829
[TBL] [Abstract][Full Text] [Related]
25. [Cross-resistance of HO-221 and various antitumor agents in sublines of mouse leukemia].
Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Fujimoto S; Tsukagoshi S; Taguchi T
Gan To Kagaku Ryoho; 1991 Feb; 18(2):201-9. PubMed ID: 1899547
[TBL] [Abstract][Full Text] [Related]
26. Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.
Wampler GL; Carter WH; Campbell ED
Cancer Invest; 1987; 5(6):523-33. PubMed ID: 3442730
[TBL] [Abstract][Full Text] [Related]
27. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
Li LH; DeKoning TF; Wallace TL
Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
[TBL] [Abstract][Full Text] [Related]
28. Mitomycin C analogues with secondary amines at position 7.
Iyengar BS; Sami SM; Tarnow SE; Remers WA; Bradner WT; Schurig JE
J Med Chem; 1983 Oct; 26(10):1453-7. PubMed ID: 6620304
[TBL] [Abstract][Full Text] [Related]
29. Potentiation of antitumor activity of pirarubicin by chlorpromazine in mice bearing doxorubicin-resistant P388 leukemia.
Shibata H; Maekawa I; Furusawa S; Kawauchi H; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):359-62. PubMed ID: 2093213
[TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of 7-N-phenyl derivatives of mitomycin C in the leukemia P388 system.
Imai R; Ashizawa T; Urakawa C; Morimoto M; Nakamura N
Gan; 1980 Aug; 71(4):560-2. PubMed ID: 7437130
[TBL] [Abstract][Full Text] [Related]
31. Inability of amphotericin B(Fungizone) or of sodium deoxycholate to alter natural drug resistance or sensitivity of transplanted murine leukemias.
Ganu UK; Khandalekar DD; Gokhale SV
Indian J Physiol Pharmacol; 1984; 28(1):21-6. PubMed ID: 6490126
[TBL] [Abstract][Full Text] [Related]
32. Influence of N-(o-methoxyphenyl)-maleimide on 5-fluorouracil cytotoxicity in Ehrlich (ascites) carcinoma.
Ambaye RY; Indap MA
Cancer Lett; 1991 Apr; 57(1):21-6. PubMed ID: 1902758
[TBL] [Abstract][Full Text] [Related]
33. Combination vincristine and VP-16-213: evaluation of drug sequence.
Jackson DV; Long TR; Rice DG; Morgan TM
Cancer Biochem Biophys; 1986 Oct; 8(4):265-75. PubMed ID: 3802048
[TBL] [Abstract][Full Text] [Related]
34. Biochemical mechanisms for the scheduled synergism of (alpha S, 5S)-2 amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid and 5-fluorouracil in P388 leukemia.
Ardalan B; Chandrasekaran B; Hrishikeshavan HJ
Cancer Chemother Pharmacol; 1985; 15(1):44-8. PubMed ID: 2408773
[TBL] [Abstract][Full Text] [Related]
35. Effect of the cisplatin-procaine complex DPR in combination with several anticancer agents on murine P388 leukemic cells in vitro and in vivo.
Pastrone I; Viale M; Cafaggi S; Mariggiò MA; Parodi A; Esposito M
Invest New Drugs; 1998-1999; 16(4):297-302. PubMed ID: 10426661
[TBL] [Abstract][Full Text] [Related]
36. Murine and human leukemias.
Burchenal JH
Bibl Haematol; 1975; (40):665-77. PubMed ID: 1100047
[TBL] [Abstract][Full Text] [Related]
37. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
[TBL] [Abstract][Full Text] [Related]
38. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
Borden EC; Sidky YA; Hatcher JF; Bryan GT
Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
[TBL] [Abstract][Full Text] [Related]
39. In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia model.
Cros S; Guilbaud N; Berlion M; Dunn T; Regnier G; Dhainaut A; Atassi G; Bizzari JP
Cancer Chemother Pharmacol; 1992; 30(6):491-4. PubMed ID: 1394807
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Elliott WL; Roberts BJ; Howard CT; Leopold WR
Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]